All lobbying filings

GRIDIRON PUBLIC AFFAIRS, LLC

Lobbying for BEREN THERAPEUTICS · Biotech/biopharmaceutical companies

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to patient access to innovative therapies,H.R. 4709 - Newborn Screening Saves Lives Reauthorization, H.R. 7118 - Genomic Answers for Children's Health

Bills named in this filing 2

H.R. 4709
Newborn Screening Saves Lives Reauthorization Act of 2025
H.R. 7118
Genomic Answers for Children’s Health Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.